It turns out that GSG2 expression in luminal A breast cancers is the lowest and its expression in basal-like breast cancer is the highest in these four subtypes of breast cancer samples (Figure 2 and Fig. S3). This evidence concerns the gene HASPIN and breast carcinoma.